Unilever was among the existing investors that supplied $22.9m for meal kit provider Gousto, increasing its funding to about $100m to date.

Based on research from the universities of Bristol and Nottingham, Exonate has now raised $9m to develop a topical eye drop for conditions including diabetic macular edema.

Baris Guzel has been promoted to principal at BMW i Ventures, almost two years after joining the unit as a senior associate.

Investors including Nan Fung and Tekla Capital have increased the ophthalmic treatment developer's series B round to $35.9m, following a Novartis-led tranche a year ago.

Martlet has reinvested in Exonate through a $1.8m funding round that increased the retinal eye drop maker's total funding to more than $11m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

UCL spinout Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.

HTGF, Think.Health Ventures and Business Angels have also supplied funding to Max Planck Institute for Biochemistry mass spectrometry spinout PreOmics.

L’Oréal’s Muriel Atias has been promoted to chief investment officer of its newly created venturing unit, Bold.

Promethera Biosciences has received $11.3m in series D funding from Itochu and $16.6m in a convertible debt round backed by Sosei.